ArticleDie Ophthalmologie2023

[Prospective noninterventional BLUE SKY study evaluating the efficacy of brolucizumab in treatment-naïve and previously treated patients with neovascular AMD].

H Faatz et al.PubMed ↗Publisher ↗

No numbers read from the abstract.